Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 247-728-7 | CAS number: 26479-35-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study performed according to GLP/OECD guildeline without deficiency.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source:Nulliparous, non-pregnant female CBA/CaCrl strain mice obtained from Charles River (UK) Ltd, Margate.
- Age at study initiation: 8 to 10 weeks old.
- Weight at study initiation: 15 to 20 g
- Housing:Group housed during acclimatisation and individually housed from Day –1 in cages.
- Diet (e.g. ad libitum):SQC(E) Rat and Mouse Maintenance Diet No 1, from Special Diets Services Ltd, Witham, UK was freely available to the animals at all times.
- Water (e.g. ad libitum):Mains water was provided, ad libitum, via cage-mounted water bottles.
- Acclimation period: 8 to 15 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C):20 to 24 degrees C
- Humidity (%):45 to 65%
- Air changes (per hr):15 to 20
- Photoperiod (hrs dark / hrs light):12/12
IN-LIFE DATES: From 17 January 2012 To 31 January 2012 - Route:
- epicutaneous, open
- Vehicle:
- DMSO
- Concentration / amount:
- 0, 10%, 25%, 50% w/v
- Route:
- other: intravenous, tail vein
- Vehicle:
- DMSO
- Concentration / amount:
- 0, 10%, 25%, 50% w/v
- No. of animals per dose:
- 5
- Details on study design:
- RANGE FINDING TESTS: A preliminary screening test was performed with one mouse. The mouse was treated by daily application of 25 µL of the test
article at the maximum suitable concentration (50% w/v in DMSO) to the dorsal surface of each ear for three consecutive days (Days 1, 2 and 3). The mouse was observed daily for five days from the initiation of treatment. Any signs of toxicity or irritation during this period were recorded.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures:3
- Exposure period: 24 hours
- Site:Outer aspect of both auditory pinnae.
- Frequency of applications:once daily
- Duration:Once daily on Days 1, 2 and 3.
- Concentrations: 0.25 mL/pinna
B. CHALLENGE EXPOSURE
- No. of exposures:1
- Day(s) of challenge:1
- Site: Tail vein injection.
- Concentrations:0.25 mL phosphate buffered saline incorporating 20 μCi of 3HTdR.
- Evaluation (hr after challenge):5 hours - Positive control substance(s):
- yes
- Remarks:
- α-hexylcinnamaldehyde formulated at a concentration of 25% in acetone / olive oil (4:1 v/v)
- Vehicle:
- dimethyl sulphoxide
- No. of animals per dose:
- 5
- Details on study design:
- RANGE FINDING TESTS:
- Compound solubility:Soluble at the maximum suitable concentration(50% w/v in DMSO).
- Irritation:no
- Lymph node proliferation response:no
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: Local Lymph Node Assay
- Criteria used to consider a positive response:Test results are expressed in terms of Stimulation Indices, the ratios of the mean scintillation counts obtained from the test groups relative to the corresponding mean scintillation count obtained from controls. The threshold level for the Stimulation Index to be considered a positive indicator of the potential to cause skin sensitisation is 3.0.
TREATMENT PREPARATION AND ADMINISTRATION:
Each mouse was manually restrained with both auditory pinnae left free. The outer aspect of both pinnae of each mouse was treated by direct
application of the appropriate test or control formulation (0.025 mL/pinna) dispensed from an automatic micro pipette.
The five groups of five female mice were subjected to application of the vehicle control, positive control or one of the test formulations to the outer
aspect of the auditory pinnae, once daily on Days 1, 2 and 3.
On Day 6 the mice were placed in a warming cabinet in order to dilate the peripheral blood vasculature and thus facilitate intravenous dosing. Each mouse was transferred to a cylindrical restrainer. A plastic syringe and fine gauge hypodermic needle were used to administer 0.25 mL phosphate
buffered saline incorporating 20 μCi of 3HTdR into a tail vein of each mouse by slow bolus injection. After this treatment, the mice were returned to
their cages.
Approximately five hours after intravenous injection of the 3HTdR, all mice were sacrificed by exposure to a rising concentration of carbon dioxide.
The interval between sacrifice and the recovery of the auricular lymph nodes was no more than fifteen minutes.
The auricular lymph nodes were located and removed using curved end forceps. Any connective tissue was removed from the capsule of the nodes. The auricular lymph nodes of each mouse were then processed for scintillation count. - Positive control results:
- The positive control article produced a Stimulation Index of 4.49.
- Parameter:
- SI
- Remarks on result:
- other: Vehicle: NA 10%: 0.55 25%: 1.22 50%: 0.67 Positive control: 4.49 10%: 330± 138.7 25%: 730 ± 565.8 50%: 401 ± 126.5 Positive control: 2693 ± 1860.1
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: Vehicle: 599± 196.1 10%: 330± 138.7 25%: 730 ± 565.8 50%: 401 ± 126.5 Positive control: 2693 ± 1860.1
- Interpretation of results:
- GHS criteria not met
- Remarks:
- Migrated information
- Conclusions:
- The Local Lymph Node Assay demonstrated that Potassium Allophonate does not have the potential to cause skin sensitisation.
The test article did not meet the criteria for classification as a sensitiser according to the Globally Harmonized System of Classification and Labelling of Chemicals (GHS).
Reference
Individual DPMs and Stimulation Index (SI)
Concentration (%w/v) in DMSO |
Group |
Animal |
DPM/ |
Mean DPM/animal |
Stimulation Index (SI)a |
Vehicle |
1 |
49 |
506 |
599 |
NA |
50 |
509 |
||||
51 |
941 |
||||
52 |
458 |
||||
53 |
583 |
||||
10 |
2 |
54 |
146 |
330 |
0.55 |
55 |
313 |
||||
56 |
421 |
||||
57 |
265 |
||||
58 |
504 |
||||
25 |
3 |
59 |
711 |
730 |
1.22 |
60 |
790 |
||||
61 |
186 |
||||
62 |
328 |
||||
63 |
1635 |
||||
50 |
4 |
64 |
389 |
401 |
0.67 |
65 |
285 |
||||
66 |
521 |
||||
67 |
540 |
||||
68 |
272 |
||||
Positive control |
5 |
69 |
1308 |
2693 |
4.49 |
70 |
1715 |
||||
71 |
1619 |
||||
72 |
3013 |
||||
73 |
5809 |
Key
DMSO dimethyl sulphoxide
NA = Not applicable
a= Stimulation Index of 3.0 or greater indicates a positive result
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
In a skin sensitisation study conducted according to OECD Testing Guideline 429 with mice, potassium allophonate did not result in any skin sensitisation effects. Therefore, the current data indicate that potassium allophonate is not a skin sensitiser.
Migrated from Short description of key information:
Potassium allophonate was evaluated for skin sensitisation in a local lymph node assay (LLNA) in mice (OECD Testing Guideline 429). None of the test animals produced a skin sensitisation stimulation index over 3 in this study. Therefore, the current data indicate that potassium allophonate is not a skin sensitiser.
Justification for selection of skin sensitisation endpoint:
Study performed under Good Laboratory Practices (GLP)/Organisation for Economic Co-operation and Development (OECD) testing guidelines.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Additional information:
- Migrated from Short description of key information:
Although no study data specifically evaluating potential respiratory sensitisation effects are available for potassium allophonate, based on the lack of human case reports indicating potassium allophonate is a respiratory sensitiser, as well as negative responses observed in both the skin sensitisation and skin irritation animal studies, potassium allophonate is not likely to be a respiratory sensitiser.
Justification for classification or non-classification
Potassium allophonate was found to be non-sensitising in a skin sensitisation study conducted in accordance with OECD Testing Guideline 429. Therefore, no classification is warranted for the skin sensitisation endpoint. No respiratory sensitisation study is available for potassium allophonate. Therefore, classification cannot be made due to lack of data.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.